All In MedTech

Indication · GI, Urology & Nephrology

Bladder cancer

Devices FDA has cleared or approved since 2000 for bladder cancer, found through the 9 FDA device types (product codes) used for it, plus device trials and research. Also searched as: bladder cancer, urothelial carcinoma.

Last checked: Nov 19, 2026Source: FDA, ClinicalTrials.gov

Devices

112

Cleared or approved since 2000

PMA and De Novo

9

Higher-risk or first-of-kind devices

Breakthrough devices

0

Authorized through June 30, 2026

Recruiting device trials

20

153 device trials in all

Devices

112 devices. PMA and De Novo devices first, then devices with the most FDA decisions. Each opens a full summary.

AllPMADe Novo510(k)
  • NMP22 BladderChek Test

    Abbott Diagnostics Scarborough, Inc. · PMA · System, Test, Tumor Marker, For Detection Of Bladder Cancer · newest 2022 · 4 decisions

  • KARL STORZ D-Light C PDD System

    KARL STORZ Endoscopy-America, Inc. · PMA · Light Source System, Diagnostic Endoscopic · newest 2022 · 2 decisions

  • Urovysion Bladder Cancer Kit

    Abbott Molecular · PMA · Test, Fluorescence In Situ Hybridization (Fish), For Bladder Cancer Detection And Monitoring For Recurrence · newest 2014 · 2 decisions

57 more devices with a free account

Showing the first 60. Narrow by pathway, or open a device type below.

Device trials

Device studies on ClinicalTrials.gov for this condition, any status, newest update first.

Open in Trial Radar

150 more trials with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.